655 related articles for article (PubMed ID: 22794260)
1. Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons.
Threlfell S; Lalic T; Platt NJ; Jennings KA; Deisseroth K; Cragg SJ
Neuron; 2012 Jul; 75(1):58-64. PubMed ID: 22794260
[TBL] [Abstract][Full Text] [Related]
2. Prefrontal Cortex-Driven Dopamine Signals in the Striatum Show Unique Spatial and Pharmacological Properties.
Adrover MF; Shin JH; Quiroz C; Ferré S; Lemos JC; Alvarez VA
J Neurosci; 2020 Sep; 40(39):7510-7522. PubMed ID: 32859717
[TBL] [Abstract][Full Text] [Related]
3. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.
Threlfell S; Clements MA; Khodai T; Pienaar IS; Exley R; Wess J; Cragg SJ
J Neurosci; 2010 Mar; 30(9):3398-408. PubMed ID: 20203199
[TBL] [Abstract][Full Text] [Related]
4. Targeted Activation of Cholinergic Interneurons Accounts for the Modulation of Dopamine by Striatal Nicotinic Receptors.
Brimblecombe KR; Threlfell S; Dautan D; Kosillo P; Mena-Segovia J; Cragg SJ
eNeuro; 2018; 5(5):. PubMed ID: 30406189
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Nigrostriatal Dopamine Release by Striatal GABA
Lopes EF; Roberts BM; Siddorn RE; Clements MA; Cragg SJ
J Neurosci; 2019 Feb; 39(6):1058-1065. PubMed ID: 30541909
[TBL] [Abstract][Full Text] [Related]
6. Polysynaptic inhibition between striatal cholinergic interneurons shapes their network activity patterns in a dopamine-dependent manner.
Dorst MC; Tokarska A; Zhou M; Lee K; Stagkourakis S; Broberger C; Masmanidis S; Silberberg G
Nat Commun; 2020 Oct; 11(1):5113. PubMed ID: 33037215
[TBL] [Abstract][Full Text] [Related]
7. Histamine H
Varaschin RK; Osterstock G; Ducrot C; Leino S; Bourque MJ; Prado MAM; Prado VF; Salminen O; Rannanpää Née Nuutinen S; Trudeau LE
Neuroscience; 2018 Apr; 376():188-203. PubMed ID: 29374538
[TBL] [Abstract][Full Text] [Related]
8. Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling.
Chuhma N; Mingote S; Moore H; Rayport S
Neuron; 2014 Feb; 81(4):901-12. PubMed ID: 24559678
[TBL] [Abstract][Full Text] [Related]
9. Metabotropic glutamate receptor 2 inhibits thalamically-driven glutamate and dopamine release in the dorsal striatum.
Johnson KA; Mateo Y; Lovinger DM
Neuropharmacology; 2017 May; 117():114-123. PubMed ID: 28159646
[TBL] [Abstract][Full Text] [Related]
10. Striatal cholinergic interneurons regulate cognitive and affective dysfunction in partially dopamine-depleted mice.
Ztaou S; Lhost J; Watabe I; Torromino G; Amalric M
Eur J Neurosci; 2018 Nov; 48(9):2988-3004. PubMed ID: 30230645
[TBL] [Abstract][Full Text] [Related]
11. Temporal components of cholinergic terminal to dopaminergic terminal transmission in dorsal striatum slices of mice.
Wang L; Zhang X; Xu H; Zhou L; Jiao R; Liu W; Zhu F; Kang X; Liu B; Teng S; Wu Q; Li M; Dou H; Zuo P; Wang C; Wang S; Zhou Z
J Physiol; 2014 Aug; 592(16):3559-76. PubMed ID: 24973407
[TBL] [Abstract][Full Text] [Related]
12. Dopamine Cells Differentially Regulate Striatal Cholinergic Transmission across Regions through Corelease of Dopamine and Glutamate.
Cai Y; Ford CP
Cell Rep; 2018 Dec; 25(11):3148-3157.e3. PubMed ID: 30540946
[TBL] [Abstract][Full Text] [Related]
13. Increased GABAergic transmission in neuropeptide Y-expressing neurons in the dopamine-depleted murine striatum.
Rubi L; Fritschy JM
J Neurophysiol; 2020 Apr; 123(4):1496-1503. PubMed ID: 32159408
[TBL] [Abstract][Full Text] [Related]
14. GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease.
Lozovaya N; Eftekhari S; Cloarec R; Gouty-Colomer LA; Dufour A; Riffault B; Billon-Grand M; Pons-Bennaceur A; Oumar N; Burnashev N; Ben-Ari Y; Hammond C
Nat Commun; 2018 Apr; 9(1):1422. PubMed ID: 29651049
[TBL] [Abstract][Full Text] [Related]
15. Multiphasic modulation of cholinergic interneurons by nigrostriatal afferents.
Straub C; Tritsch NX; Hagan NA; Gu C; Sabatini BL
J Neurosci; 2014 Jun; 34(25):8557-69. PubMed ID: 24948810
[TBL] [Abstract][Full Text] [Related]
16. Striatal cholinergic interneurons Drive GABA release from dopamine terminals.
Nelson AB; Hammack N; Yang CF; Shah NM; Seal RP; Kreitzer AC
Neuron; 2014 Apr; 82(1):63-70. PubMed ID: 24613418
[TBL] [Abstract][Full Text] [Related]
17. Coordinated Postnatal Maturation of Striatal Cholinergic Interneurons and Dopamine Release Dynamics in Mice.
McGuirt AF; Post MR; Pigulevskiy I; Sulzer D; Lieberman OJ
J Neurosci; 2021 Apr; 41(16):3597-3609. PubMed ID: 33664134
[TBL] [Abstract][Full Text] [Related]
18. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease.
Ztaou S; Amalric M
Neurochem Int; 2019 Jun; 126():1-10. PubMed ID: 30825602
[TBL] [Abstract][Full Text] [Related]
19. Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons.
Kharkwal G; Brami-Cherrier K; Lizardi-Ortiz JE; Nelson AB; Ramos M; Del Barrio D; Sulzer D; Kreitzer AC; Borrelli E
Neuron; 2016 Jul; 91(1):67-78. PubMed ID: 27387649
[TBL] [Abstract][Full Text] [Related]
20. Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing.
Cachope R; Mateo Y; Mathur BN; Irving J; Wang HL; Morales M; Lovinger DM; Cheer JF
Cell Rep; 2012 Jul; 2(1):33-41. PubMed ID: 22840394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
